Professor Dr. / Hanan Hasan Kadry Afify
Pharmaceutical Organic Chemistry
hanan.kadry@pharma.cu.edu.eg
Latest List of Publications
1) El-Anany M, Soliman L N, El-Ansary A K, Kadry H H* and Abdel aziz A. Synthesis and
Antimicrobial Activity of Certain Pyrimidine Derivatives. Bull. Fac. Pharm. Cairo Univ.1999
; 37(3); 53-64
2) Shaaban M A, AbouSier A H, El-Ansary A K, Kadry* H H and Abd El-Latif H A. Synthesis and Pharmacological Activities of Certain Pyrazolotriazolo pyrimidines and Pyrazolotriazepine
Derivatives. Bull. Fac. Pharm. Cairo Univ. 2001; 39, 67-77
3) Shaaban M A, AbouSier A H, El-Ansary A K and Kadry* H H. Synthesis of Certain
Pyrazolopyrimidines of Pharmaceutical Interest. Bull. Fac. Pharm. Cairo Univ. 2002; 40(1);
15-22.
4) Kadry* H H and Shouman S. Synthesis and in vitro Antitumor Activity of Certain
Pyrazolo [3,4-d] Pyrimidines, Inhibitors of EGFR Tyrosine Kinase Activity. Az. J. Pharm.
Sci. 2006; 34; 237-247.
5) Abdel-Hakeem M, Abuel-Maaty S M and Kadry* H H. Synthesis and Antimicrobial Activity of Some 6-(4-Fluorophenyl)Pyridazine Derivatives. Bull. Fac. Pharm. Cairo Uni., 2007; 45(2); 39-46.
6) Abouzid K, Taher A T and Kadry*H H, Design, Synthesis and Antihypertensive Activity of Certain Pyrazolo Pyrimidines With Aryl Piperazine Side Chains. Bull. Fac. Pharm. Cairo Univ. 2007; 45(2); 87-97.
7) Moneer A A, Taher A and Kadry H H*, Synthesis of Certain Thienopyrimidine Derivatives of Possible Pharmaceutical Interest. Bull. Fac. Pharm. Cairo Univ. 2007; 45(3); 109-116.
8) Abdel- Hakeem M, Abuel- Maaty S M, Kadry H H* and Taha R A, Design and Synthesis of New 6-Substituted Pyridazine Derivatives as Hypotensive Agents. Bull. Fac. Pharm. Cairo Univ. 2008; 46(3);
9) Refaat H M, Khalil O M and Kadry H H*, Synthesis and Anti-inflammatory Activity of Certain Piperazinylthienyl pyridazine Derivatives. Arch. Pharm. Res. 2007; 30(7); 803-811.
10) El-Sabbagh O I, Shabaan M A, Kadry H H* and Saad Al-Din E, Synthesis of New Nonclassical Acridines, Quinolines, and Quinazolines Derived from Dimedone for Biological Evaluation. Arch. Pharm. Chem. Life Sci. 2010; 9; 519–527.
11) El-Sabbagh O I, Shabaan M A, Kadry H H* and Saad Al-Din E, New Octahydroquinazoline Derivatives: Synthesis and hypotensive activity. Eur. J. Med. Chem. 2010; 45; 5390-5396.
12) Hassan G A, Kadry H H* , Abou-Seri S M , Ali M M and Mahmoud A E. Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d] pyrimidines andrelated pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line. Bioorg. Med. Chem. 2011; 19, 6808–6817.
13) Elansary A K, Kadry H H*, Ahmed E M and Motawi A S. Design, synthesis and in vitro PDE4 inhibition activity of certain quinazolinone derivatives for treatment of asthma. Med Chem Res. 2012; 21; 3327–3335.
14) Elansary A K, Kadry H H*, Ahmed E M and Motawi A S. Design, synthesis, and biological activity of certain quinazoline dione derivatives as potent phosphodiestrase4 inhibitors. Med Chem Res. 2012; 21; 3557–3567.
15) Elansary A K, Moneer A A, Kadry H H* and Gedawy E A. Synthesis and Anticancer Activity of Some Novel Fused Pyridine Ring System. Arch Pharm Res.2012; 35 (11); 1909-1917.
16) Kandeel M M, Abdou N A, Kadry H H*, El-Masry R M. Synthesis and In Vitro Antitumor Activity of Some New Mannich Bases, International Journal of Chem Tech Research, 2013; 5(1); 401-408
17) Taher A T, Kadry H H*, Allarà M, Di Marzo V, Abadi A H, and Abouzid K. Synthesis and binding study of certain 6-arylalkanamides as molecular probes for cannabinoid receptor subtypes, J. Enzyme Inhibition and Med. Chem.2013; 28(3); 436-439 .
18) Elansary A K , Moneer A A , Kadry H H* and Gedawy E M. Synthesis and antitumour activity of certain pyrido[2,3-d ] pyrimidine and 1,8-naphthyridine derivatives, J. Chem. Res.2014; 38; 147-153 .
19) Kandeel M M, Abdou N A, Kadry H H*, El-Masry R M. Synthesis and antitumor activity of some novel heterocyclic compounds derived from chalcone analogues, Org. chem.,An indian journal, 2014;10(8),295-307.
20) Kadry H H. Synthesis, biological evaluation of certain pyrazolo[3,4-d]pyrimidines as novel anti-inflammatory and analgesic agents, Med. Chem. Res., 2014; 23;5269–5281.